Impact Factor 2025

Search

Search Results

##search.searchResults.foundPlural##

Effects of the availability of new oral anticoagulants in patients with non-valvular atrial fibrillation in the real world: the NAIF study

Francesco Ventrella, Franco Mastroianni, Sergio Cappello, Luigi Iamele, Samantha Errico, Massimo Errico

176-183

06-07-2016

https://doi.org/10.4081/itjm.2016.715

1702

PDF: 1104

HTML: 358
Assessment and predictors of inappropriate dose of direct oral anticoagulants

Mosaad O. Almegren

09-01-2024

https://doi.org/10.4081/itjm.2024.1679

1346

pdf: 651

HTML: 175
Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation

Tommaso Sacquegna, Anna Zaniboni, Andrea Rubboli, Gaetano Procaccianti, Michela Crisci, Fabiola Maioli, Giorgia Arnone, Giuseppe Di Pasquale

314-322

15-12-2015

https://doi.org/10.4081/itjm.2015.468

2166

PDF: 1090

HTML: 1304
The incidence of bleeding in patients with nonvalvular atrial fibrillation using anticoagulants: a real-world report with the biggest Vietnamese data

Bui The Dung, Cao Ngoc Mai Han, Tran Hoa, Nguyen Thanh Hien

17-02-2025

https://doi.org/10.4081/itjm.2025.1807

2438

PDF: 596

HTML: 1
The practical management of bleedings during treatment with direct oral anticoagulants: the emergency reversal therapy

Luca Masotti, Giancarlo Landini, Grazia Panigada

48-58

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.48

1633

PDF: 1160
Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics

Luca Masotti, Mauro Campanini

1-7

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.1

13943

PDF: 3270
Stroke prevention in atrial fibrillation: findings from Tuscan FADOI Stroke Registry

Luca Masotti, Rinaldo Innocenti, Stefano Spolveri, Irene Chiti, Grazia Panigada, Cristiana Seravalle, Giancarlo Landini, Alberto Fortini, Rino Migliacci, Raffaele Laureano, for Tuscan FADOI Stroke Registry Investigators

134-140

12-06-2014

https://doi.org/10.4081/itjm.2014.450

1863

PDF: 1439

Appendix: 653

HTML: 636
Direct oral anticoagulants in real practice: which doses for which patients. Limitations and bleeding risk compared to vitamin K antagonists

Giancarlo Landini, Luca Masotti

41-47

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.41

1107

PDF: 991
Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Cecilia Becattini, Maurizio Paciaroni, Daniel Augustin Godoy, Roberto Cappelli, Giancarlo Landini, Grazia Panigada, Ido Iori, Domenico Prisco, Giancarlo Agnelli

8-21

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.8

1555

PDF: 1097
A review on management of antiphospholipid syndrome in clinical practice

Carmine Siniscalchi, Pietro Rossetti, Gaetano Carolla, Pierpaolo Di Micco, Adriano Stella, Michele Riva

13-09-2023

https://doi.org/10.4081/itjm.2023.1649

3484

PDF: 1411

HTML: 82
Vorapaxar

Gianluca Airoldi, Mauro Campanini

88-95

24-04-2013

https://doi.org/10.4081/itjm.2013.88

1389

PDF: 820

HTML: 243
Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes

Andrea Rubboli

22-28

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.22

1211

PDF: 907
Pharmacological interactions in novel oral anticoagulants, statins, and hypertension drugs in patients treated with direct-acting antivirals for hepatitis C: a Delphi Consensus project

Ivan Gentile, Giancarlo Agnelli, Angelo Avogaro, Claudio Borghi, Alessia Ciancio, Ernesto Claar, Patrizio Pasqualetti, Pasquale Perrone Filardi

25-11-2024

https://doi.org/10.4081/itjm.2024.1846

2785

PDF: 568

SUPPLEMENTARY MATERIAL: 330

ACKNOWLEDGMENTS: 289

HTML: 197
Apixaban

Gianluca Airoldi, Mauro Campanini

128-134

07-03-2013

https://doi.org/10.4081/itjm.2011.128

1406

PDF: 2129
New oral anticoagulants: key messages for clinicians

Matteo Giorgi-Pierfranceschi, Chiara Cattabiani, Francesco Dentali

74-84

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.74

1468

PDF: 1061
Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows

Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Daniel Godoy, Grazia Panigada, NiccolÃ² Napoli, Giancarlo Landini, Roberto Cappelli, Ido Iori, Domenico Prisco, Giancarlo Agnelli

153-169

23-10-2012

https://doi.org/10.4081/itjm.2012.153

1901

PDF: 2383
Cryptogenic stroke

Michele Stornello, Roberto Cappellani, Giuseppe Micieli, Simona Sacco, Stefano Spolveri, Roberto Sterzi, Danilo Toni, Antonio Carolei

185-194

30-09-2016

https://doi.org/10.4081/itjm.2016.682

2125

PDF: 1365

HTML: 616
Pregnancy and heart disease: what Internists should know

Riccardo Gerloni, Domenico Panuccio

288-304

11-09-2017

https://doi.org/10.4081/itjm.2017.815

1715

PDF: 893

HTML: 287
Acute severe renal failure in a patient receiving apixaban: a case report

Attilia Maria Pizzini, Chiara Fantoni, Stefania Zaccaroni, Mauro Silingardi

09-04-2024

https://doi.org/10.4081/itjm.2024.1718

1154

PDF: 606

HTML: 84
Sex differences in adverse drug reaction and liver disease

Ombretta Para, Pietro Crispino, Nunzia Barone, Sara Macis, Laura Airasca, Paola Gnerre, Cecilia Politi

15-22

20-03-2018

https://doi.org/10.4081/itjm.2018.893

2450

PDF: 1114

HTML: 504
Portal vein thrombosis and Budd-Chiari syndrome as onset of polycythemia vera

Aurelio Seidita, Delia Sprini, Accursia BongiovÃ¬, Tiziana Catalano, Filippo Barbiera, Maria Accardi, Pasquale Mansueto, Antonio Carroccio

196-205

19-09-2013

https://doi.org/10.4081/itjm.2013.196

2120

PDF: 1451

HTML: 2030
Results of prospective multicenter study on heart failure on Campania Internal Medicine wards: the FASHION study

Fernando Gallucci, Ilaria Ronga, Andrea Fontanella, Generoso Uomo, and the FASHION Study Group

184-190

14-06-2017

https://doi.org/10.4081/itjm.2017.705

1654

PDF: 893

HTML: 462
ORAL COMMUNICATION | Comparison of HAS-BLED and DOAC score for bleeding risk prediction in patients with non-valvular atrial fibrillation treated with direct oral anticoagulants: a real-world cohort study.

A. Trovati, S. Ballestri, M. Bergamini, F. Zanni, B. Cuneo, L. Orlandi, M. Pasquinelli, M. Capitelli

22-05-2026

https://doi.org/10.4081/itjm.2026.2579

233

PDF: 128
Thrombophilias: therapeutic employment of direct oral anticoagulants in venous hypercoagulable states

Federico Cacciapuoti

136-142

17-09-2020

https://doi.org/10.4081/itjm.2020.1296

1089

PDF: 760

HTML: 361
Utility of the aspirin and P2Y12 response assays to determine the effects of antiplatelet agents in patients with subdural hematoma undergoing neurosurgery

Ombretta Para, Christian Carleo, Francesco Bucci, Lucia Lipari, Asim Raza, Edoardo Cesaroni, Chiara La Rovere, Simone Orlandini, Gastone Pansini, Alberto Parenti, Giovanni Muscas, Alessandro Della Puppa

14-07-2025

https://doi.org/10.4081/itjm.2025.1926

939

PDF: 849

HTML: 0
Management of major bleeding in patients treated with direct oral anticoagulants: from experience to standardized protocols

Sara Mascia, Anna Maria Ferrari, Nicola Macarone Palmieri, Elisa Romagnoli, Chiara Catena, Serena Scarabottini, Francesca Mori, Lucio Brugioni

43-48

17-06-2020

https://doi.org/10.4081/itjm.2020.1224

1228

PDF: 794

HTML: 259
ORAL COMMUNICATION | Outcomes of direct oral anticoagulants in unusual-site thrombosis: impact of active cancer

S. Guglielmo, M. Lovisotto, L. Scarano, E. De Bon, S. Barbar

22-05-2026

https://doi.org/10.4081/itjm.2026.2592

203

PDF: 140
Gender medicine: an up-date

Cecilia Politi, Tiziana Ciarambino, Flavia Franconi, Lucrezia De Feudis, Maria Carolina Mayer, Alessandra Martignoni, Ilaria Giovi, Michela Tonani, Salvatore La Carrubba, Anna Maria Moretti, Carmen Martino, Giovanni Scanelli

96-106

24-04-2013

https://doi.org/10.4081/itjm.2013.96

2420

PDF: 1072

HTML: 507
A dangerous adverse event in the use of dabigatran

Manuel Monti, Giovanni Maria Vincentelli, Francesco Borgognoni, Giuseppe Murdolo, Feliciano Menghini

250-251

09-11-2015

https://doi.org/10.4081/itjm.2015.629

1791

PDF: 1077

HTML: 270
Treatment and secondary prophylaxis of venous thromboembolism with direct oral anticoagulants in patients with severe hereditary thrombophilia

Pasquale Madonna, Anna Guida, Maria Gabriella Coppola, Paolo Tirelli, Ernesto Grasso

18-03-2021

https://doi.org/10.4081/itjm.2021.1351

1484

PDF: 701

HTML: 54
The management of the patient with acute pancreatitis: from evidence to clinical practice

Cristina Cenci, Tea Restuccia, Paola Gnerre, Irene Chiti, Laura Betti, Milena Micati, Claudio Tana

220-245

11-09-2017

https://doi.org/10.4081/itjm.2017.748

3144

PDF: 1403

HTML: 1377
Unveiling silent threats: incidental diagnosis and conservative management of spontaneous isolated celiac artery dissection

Guido Faggian, Roberto Faggian, Michela Salzano, Ciro Stavolo, Teresa Argenziano, Andrea Diglio, Angela Faggian

20-01-2026

https://doi.org/10.4081/itjm.2026.2385

453

PDF: 304

HTML: 22
CO26 | Direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer: a FADOI survey among Campanian Internal Medicine wards E. Marrone¹, C. Arturo², F. Cannavacciuolo³, D. D’Ambrosio⁴, F. Gallucci¹, M. Amitrano³, C. Di Gennaro², P. Morella¹, A. Maffettone⁵ | ¹UOC Medicina 3, AORN A Cardarelli, Napoli, ²UOC Medicina Generale, PO A. Rizzoli, Ischia (NA), ³UOC Medicina Interna, AO Moscati, Avellino, ⁴UOC Medicina Generale, PO Aversa (CE), ⁵UOC Medicina ad indirizzo cardiovascolare e dismetabolico AORN dei Colli, Ospedale Monaldi, Italy

25-08-2025

https://doi.org/10.4081/itjm.2025.2178

253
Optimal duration of anticoagulant therapy in patients with venous thromboembolism

Gualtiero Palareti

235-244

14-09-2018

https://doi.org/10.4081/itjm.2018.1077

1783

PDF: 2003

HTML: 260
Quantifying treatment effect: relative and absolute measures in clinical research

Alberto Maino, Lorenza Bertù, Alessandro Squizzato, Paola Piccolo, Fulvio Pomero

16-04-2026

https://doi.org/10.4081/itjm.2026.2386

731

PDF: 454

HTML: 123
Anticoagulation in the early phase of non-valvular atrial fibrillation-related acute ischemic stroke: where do we stand?

Luca Masotti, Elisa Grifoni, Alessandro Dei, Vieri Vannucchi, Federico Moroni, Grazia Panigada, Stefano Spolveri, Giancarlo Landini

24-31

03-01-2019

https://doi.org/10.4081/itjm.2019.1111

1551

PDF: 940

HTML: 71
Management of chronic obstructive pulmonary disease: criteria for an appropriate hospital discharge

Marco Candela, Ruggero Pastorelli, Antonio Sacchetta, Mauro Campanini, Leonardo M. Fabbri, Carlo Nozzoli

218-230

19-09-2013

https://doi.org/10.4081/itjm.2013.218

1800

PDF: 1270

HTML: 877
The management of the patient with non-variceal upper gastrointestinal bleeding: from evidence to clinical practice

Maddalena Zippi, Mariella Frualdo, Luciano Mucci, Marta Zanon, Chiara Marzano, Claudio Cassieri, Paola Gnerre, Pietro Crispino

246-252

27-12-2016

https://doi.org/10.4081/itjm.2016.713

1746

PDF: 1165

HTML: 303
An unusual cause of massive hemoptysis

Silvia Maestroni, Martino Cellerini, Antonio Brucato

71-74

01-07-2016

https://doi.org/10.4081/itjm.2016.738

1551

PDF: 1109

HTML: 393
The management of heart failure: a FADOI survey in the setting of Internal Medicine Units

Fernando Gallucci

16-02-2023

https://doi.org/10.4081/itjm.2023.1573

2336

PDF: 773

HTML: 13
How artificial intelligence during the pandemic modified the role of a biomarker as d-dimer

Pierpaolo Di Micco, Francesca Futura Bernardi, Giovanni Maria Fusco, Alessandro Perrella

20-11-2023

https://doi.org/10.4081/itjm.2023.1656

1397

PDF: 599

HTML: 30
P149 | Acute and long-term management of venous thromboembolism through the post-COVID-19 pandemic era M.A. Wu¹, A. Taino¹, P. Facchinetti¹, V. Rossi¹, S. Berra², R. Celano¹, F. Urso¹, A. Meschia¹, R. Colombo³ | ¹Division of Internal Medicine, Luigi Sacco Hospital, University of Milan, ²Department of Biomedical and Clinical Sciences, University of Milan, ³Division of Anesthesiology and Intensive Care, Luigi Sacco Hospital, University of Milan, Italy

28-08-2025

https://doi.org/10.4081/itjm.2025.2345

207
Equivalent/generic drugs use. To whom? When? How?

Andrea Fontanella

77-79

08-05-2014

https://doi.org/10.4081/itjm.2014.472

1216

PDF: 998

HTML: 293

1 - 43 of 43 items

© PAGEPress 2008-2026 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.